1. 733 Integrative molecular profiling of high-grade primary prostate cancer identifies patients with a biomarker profile that favors the combination of standard of care (SOC) therapy with immunotherapy. (10th December 2020) Authors: Gjini, Evisa; Trillo-Tinoco, Jimena; Browne, Andrew; Powles, Ryan; Wang, Tai; Tauras, Christine; Lako, Ana; Ferrer-Luna, Ruben; Bleicher, Zoe; Consedine, Timothy; Zhou, Chensheng; Kelemen, Evan; Lewin, Anne; King, Catherine; Bhattacharya, Sumit; Bell-Temin, Harris; Dongre, Ashok; Nelson, David; H... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A438 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 733 Integrative molecular profiling of high-grade primary prostate cancer identifies patients with a biomarker profile that favors the combination of standard of care (SOC) therapy with immunotherapy. (9th November 2020) Authors: Gjini, Evisa; Trillo-Tinoco, Jimena; Browne, Andrew; Powles, Ryan; Wang, Tai; Tauras, Christine; Lako, Ana; Ferrer-Luna, Ruben; Bleicher, Zoe; Consedine, Timothy; Zhou, Chensheng; Kelemen, Evan; Lewin, Anne; King, Catherine; Bhattacharya, Sumit; Bell-Temin, Harris; Dongre, Ashok; Nelson, David; H... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A777 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗